{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_pemetrexed",
          "name": "Pemetrexed"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_lapatinib",
          "name": "Lapatinib"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_carmustine",
          "name": "Carmustine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_trametinib",
          "name": "Trametinib"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_anaplastic_lymphoma_kinase_inhibitor",
          "name": "Anaplastic lymphoma kinase inhibitor"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_nivolumab",
          "name": "Nivolumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_atezolizumab",
          "name": "Atezolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_temo",
          "type": "Target",
          "label": "OffTargetTemozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_temo",
          "type": "Pathway",
          "label": "RiskPathwayTemozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_temo",
          "type": "Phenotype",
          "label": "AdversePhenotypeTemozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_dexa",
          "type": "Target",
          "label": "OffTargetDexamethasone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_dexa",
          "type": "Pathway",
          "label": "RiskPathwayDexamethasone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_dexa",
          "type": "Phenotype",
          "label": "AdversePhenotypeDexamethasone",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_temozolomide",
          "target": "n_ot_temo",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向组织"
        },
        {
          "source": "n_ot_temo",
          "target": "n_rp_temo",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_temo",
          "target": "n_adv_temo",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_temo",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        },
        {
          "source": "drug_dexamethasone",
          "target": "n_ot_dexa",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能影响非靶向组织"
        },
        {
          "source": "n_ot_dexa",
          "target": "n_rp_dexa",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "风险通路关联"
        },
        {
          "source": "n_rp_dexa",
          "target": "n_adv_dexa",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_dexa",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "Temozolomide 对神经系统肿瘤的长期影响未充分研究",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "Dexamethasone 可能加重感染风险及其他并发症",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "Temozolomide 与 Dexamethasone 对细胞代谢的非靶向效应",
      "药物的安全性在特殊人群中的适用性"
    ],
    "falsification_tests": [
      "是否存在支持 Temozolomide 安全性的长期数据?",
      "Dexamethasone 使用中的不良反应是否显著?"
    ],
    "next_focus_for_pi": [
      "提供更多关于这两个药物安全性的数据",
      "针对潜在风险进行详细机制研究"
    ]
  }
}